Journals / Kocatepe Tıp Dergisi / 2026 / Cilt: 26 Sayı: 3

EVALUATION OF THE FREQUENCY OF SEXUAL DYSFUNCTION IN PATIENTS WITH DIABETIC RETINOPATHY

DİYABETİK RETİNOPATİLİ HASTALARDA CİNSEL DİSFONKSİYON SIKLIĞININ DEĞERLENDİRİLMESİ

Betül Dertsiz Kozan(SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, DİYARBAKIR GAZİ YAŞARGİL SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ, CERRAHİ TIP BİLİMLERİ BÖLÜMÜ, GÖZ HASTALIKLARI ANABİLİM DALI)0000-0002-0667-2866
Mehmet Sinan Atkın(Gaziantep Şehir Hastanesi)0000-0003-3054-6031
Bahadır Utlu(Erzurum Şehir Hastanesi)0000-0002-7129-2181
Pages
203–206
Publication Date
2025-07-16
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

ED development increases in diabetic patients even if DRP does not develop.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Diabetes is a systemic disease that causes endothelial dysfunction and atherosclerosis.
📊
Key Findings & Data:MATERIAL AND METHODS: In our study, participants/patients were divided into three groups: Group 1 with DRP, Group 2 without DRP but with diabetes, and Group 3 as a control group consisting of healthy cases.
💡
Conclusion & Impact:ED development increases in diabetic patients even if DRP does not develop.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Diyabetik retinopati · Erektil disfonksiyon · Diyabet

Abstract

OBJECTIVE: Diabetes is a systemic disease that causes endothelial dysfunction and atherosclerosis. It was aimed to evaluate the frequency of erectile dysfunction (ED) in male patients being followed up due to diabetic retinopathy (DRP) and in male diabetic patients without DRP. MATERIAL AND METHODS: In our study, participants/patients were divided into three groups: Group 1 with DRP, Group 2 without DRP but with diabetes, and Group 3 as a control group consisting of healthy cases. The International Erectile Function Form questionnaire was applied to all cases to evaluate ED. According to this survey, scores between 0 and 10 were classified as severe; between 11 and 16 as moderate; between 17 and 21 as mild to moderate; between 22 and 25 as mild; and between 26 and 30 as no ED. RESULTS: A total of 75 cases were included in the study, 25 cases in group 1, 25 cases in group 2 and 25 cases in group 3. According to the survey scoring, group 1 is; 2 (8%) had no ED, 3 (12%) had mild ED, 18 (72%) had mild-moderate ED, 1 (4%) had moderate ED, 1(4%) had severe ED. It has been observed that ED is present. In Group 2, 15 (60%) had no ED, 3 (12%) had mild ED, 5 (20%) had mild-moderate ED, 1 (4%) had moderate ED, 1 (4%) had mild ED. ) was observed to have serious ED. In Group 3 controls, 1 (4%) had mild-moderate ED, 4 (16%) had mild ED, and 20 (80%) had no ED. An increase in the degree of ED was observed as age increased (p<0.05). Diabetes increases the occurrence of ED with or without DRP compared to the control group (p<0.05). CONCLUSIONS: Diabetes causes serious consequences that affect the quality of life of patients by causing microvascular damage and neuropathy. ED is more common in patients with diabetes, especially if retinopathy has developed, and it reduces the quality of life of these patients. ED development increases in diabetic patients even if DRP does not develop.

Özet

AMAÇ: Diyabet endotel disfonksiyonu ve ateroskleroza neden olan sistemik bir hastalıktır. Diyabetik retinopati(DRP) nedeni ile takipli erkek olgularda ve DRP olmayan diyabetli erkek olgularda erektil disfonksiyon (ED) sıklığının değerlendirilmesi amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmamızda grup 1’de DRP’si olan, grup 2’de DRP’si olmayan fakat diyabeti olan, grup 3’de sağlıklı olguların olduğu kontrol grubuna ayrıldı. Tüm olgularda ED değerlendirilmesi için Uluslararası Erektil İşlev Formu anketi uygulanmıştır. Bu ankete göre skoru (0-10) arasında olanlar ciddi; (11-16) olanlar orta; (17-21) olanlar hafif-orta; (22-25) olanlar hafif; (26-30) ED yok olarak değerlendirildi. BULGULAR: Çalışmaya grup 1’de 25 olgu, grup 2’de 25 olgu ve grup 3’de 25 olgu olmak üzere toplam 75 olgu dahil edilmiştir. Anket skorlamasına göre grup 1’de; 2 (%8)’sinde ED yok, 3 (%12)’ünde hafif ED, 18 (%72)’inde hafif-orta ED, 1 (%4)’inde orta ED, 1(%4)’inde ciddi ED olduğu gözlenmiştir. Grup 2’de ;15 (%60)’inde ED yok, 3 (%12)’ünde hafif ED, 5 (%20)’inde hafif-orta ED, 1 (%4)’inde orta ED, 1 (%4)’inde ciddi ED olduğu gözlenmiştir. Grup 3’de ise 1 (%4)’inde hafif-orta ED, 4(%16)’ünde hafif ED, 20 (%80)’sinde ED yok olarak gözlemlenmiştir. Yaş arttıkça ED derecesinde artış gözlenmiştir (p<0.05). Diyabet, DRP olsun ya da olmasın ED oluşumunu kontrol grubuna göre arttırmaktadır (p<0.05). SONUÇ: Diyabet, mikrovasküler hasar ve nöropati oluşturarak hastalarda hayat kalitesini etkileyen ciddi sonuçlar doğurmaktadır. ED, diyabetli hastalarda özellikle retinopati gelişmiş ise daha sık görülmekte ve bu hastaların yaşam kalitesini düşürmektedir. Diyabet hastalarında DRP gelişmese bile ED gelişimi artmaktadır.

🔖

Cite This Article

Kozan, B. D., Durusoy, G. K., Atkın, M. S., Utlu, B. (2025). EVALUATION OF THE FREQUENCY OF SEXUAL DYSFUNCTION IN PATIENTS WITH DIABETIC RETINOPATHY. Kocatepe Tıp Dergisi, Cilt: 26 Sayı: 3, 203–206. https://doi.org/10.18229/kocatepetip.1455757

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (23)

  1. Satman I, Yilmaz T, Sengul A et al. Population-based study of diabetes and risk characteristics in Turkey: Results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002;25(9):1551-6.
  2. Satman I, Bayirlioglu S, Okumus F et al. TURDEP-II Study Group. Estimates and Forecasts on the Burden of Prediabetes and Diabetes in Adult and Elderly Population in Turkiye. Eur J Epidemiol. 2023;38(3):313-23.
  3. Johannes CB, Feldman HA, Derby CA et al. Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts Male Aging Study, J. Urol. 2000;163:460–3.
  4. Nicolosi A, Moreira ED, Shirai M et al. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction, Urology. 2003;61:201–6.
  5. Hermans MP, Ahn SA, Rousseau MF. Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes. Diabetes Metab. 2009;35(6):484-9.
  6. Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction, Urology. 1997;49:822–30.
  7. Jordan A. 1st International Erectile dysfunction Meeting Plymouth, UK: Health Publication, Ltd. 2000;7:11-26.
  8. Aytac IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 some possible policy consequences. BJU Int. 1999;84(1):50-6.
  9. Champion HC, Bivalacqua TJ, Hyman AL et al. Gene transfer of endothelial nitric oxide syntase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA. 1999;96(20):648-52.
  10. Naylor AM. Endogenous neurotransmitters mediating penile erection. Br J Urol 1998;81(3):424-31.
  11. Rajfer J, Aronson WJ, Bush PA et al. Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med. 1992;326(2):90-4.
  12. Ganz P, Vita JA. Testing endothelial vasomotor function:Nitric oxide, a multipotent molecule. Circulation 2003;108(17):2049-53.
  13. Behrendt D, Ganz P. Endothelial function: From vascular biology to clinical applications. Am J Cardiol. 2002;90(10):40-8.
  14. Bocchio M, Desideri G, Scarpelli P et al. Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol. 2004;171(4):1601-4.
  15. Sullivan ME, Thompson CS, Daswood MR et al. Nitric oxide and penile erection: Is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res. 1999;43(3):658-65.
  16. Goldstein I. The mutually reinforcing triad of depressive symptoms, cardiovascular disease and erectile dysfunction. Am J Cardiol 2000;86(2A):41-5.
  17. Goldstein I. Screening for erectile dysfunction: Rationale Int J Impot Res. 2000;12(4):147-54.
  18. Virag R, Bouilly P, Frydman D. Is impotence an arterial disorder? A study of arteryal risk factors in 440 impotence men. Lancet 1985;1(8422):181-4.
  19. Ünal M, Aydın Y, Üstün İ ve ark. Metabolik Sendrom Hastalarında Erektil Disfonksiyonun Sıklığı. Konuralp Medical Journal. 2014;6(1):11-6.
  20. Zambon JP, Mendonça RR, Wroclawski ML et al. Cardiovascular and metabolic syndrome risk among men with and without erectile dysfunction: Case-control study. Sao Paulo Med J. 2010;128(3):137-40.
  21. Solomon H, Man J, Wierzbicki AS et al. Erectile dysfunction: Cardiovascular risk and the role of the cardiologist. Int J Clin Pract. 2003;57(2):96-9.
  22. Jones RWA, Rees RW, Minhas S et al. Oxygen free radicals and the penis. Expert Opin Pharmacother 2002;3(7):889-97.
  23. Henis O, Shahar Y, Steinvil A et al. Erectile dysfunction is associated with severe retinopathy in diabetic men. Urology. 2011;77(5):1133-6.